Forschung

Direkt zum Inhalt | Direkt zur Navigation

Benutzerspezifische Werkzeuge

Sektionen
Hepatitis-C-Virus
Sie sind hier: Startseite / Forschung / Hepatitis-C-Virus

Hepatitis-C-Virus

Ausgewählte Publikationen des Instituts zum Thema Hepatitis-C-Virus - HCV (chronologisch sortiert)

 


Wiesmann F, Naeth G, Sarrazin C, Berger A, Kaiser R, Ehret R, Knechten H, Braun P. (2015). Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors. Med Microbiol Immunol. 204(4): 515-525. www.ncbi.nlm.nih.gov/pubmed/25398515

Sierra S, Knops E, Sikorski AM, Beggel B, Kalaghatgi P, Lengauer T, Keitel V, Goeser T, Esser S, von Hahn T, Peuser I, Qurishi N, Scholten S, Däumer M, Kaiser R. (2015). Hepatitis C Virus Screening Project of Patients on current anti-HCV Therapy. Reviews in Antiviral Therapy & Infectious Diseases. 568. www.ncbi.nlm.nih.gov/pubmed/Abstract 70

Scholten S, Spengler U, Pollok JM, Boeseke C, Rockstroh JK, Mues M, Schneeweiss S, Knechten H, Kaiser R, Sierra S. Triple-DAAs in HIV/HCV-GT4 coinfection with post-LTX-fibrosing cholestatic hepatitis; 2015; Düsseldorf, Gemany. pp. Abstract PW 102.

Rupp D, Dietz J, M. SA, Sierra S, Brown R, Pietschmann T, Kaiser R, Bartenschlager R. (2015). A phenotypic NS3-protease inhibitor resistance assay to characterize resistance-associated mutations in patients. J Viral Hepat. 22(Supplement S2): 93.

De Luca A, Di Giambenedetto S, Lo Presti A, Sierra S, Prosperi M, Cella E, Giovanetti M, Torti C, Caudai I, Vicenti I, Saladini F, Almi P, Grima P, Blanc P, Fabbiani M, Rossetti B, Gagliardini R, Kaiser R, Ciccozzi M, Zazzi M. (2015). Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors. Open Forum Infectious Diseases. 2(2): 1-9.

Chueca N, Fernandez-Caballero JA, Alvarez M, Sanchez A, A. L-BJ, Merida MD, Sierra- Aragon S, Kaiser R, Garcia F. (2015). An Allele-Specific RealTime PCR assay for the detection of Q80K polymorphism in NS3 protease of HCV genotype 1a. Reviews in Antiviral Therapy & Infectious Diseases 562. www.ncbi.nlm.nih.gov/pubmed/Abstract 62


Sirkoski AM, Sierra S, Lübke N, Schelhorn S, Lengauer T, Erhardt A, Reuter S, Goeser T, Esser S, Kaiser R. (2012). HCV screening project of patients on dual interferon-alpha and ribavirin therapy. Antiviral Ther. 17(Suppl. 1): A99.

Sirkoski AM, Sierra S, Lübke N, Schelhorn S, Lengauer T, Ehrhardt A, Reuter S, Goeser T, Esser S, Kaiser R. (2012). Hepatitis C Virus screening project of patients on dual interferon alpha and rivabirin therapy. Reviews in Antiviral Therapy & Infectious Diseases. 272.

Reuter S, Oette M, Wilhelm FC, Beggel B, Kaiser R, Balduin M, Schweitzer F, Verheyen J, Adams O, Lengauer T, Fatkenheuer G, Pfister H, Haussinger D. (2011). Prevalence and characteristics of hepatitis B and C virus infections in treatment-naive HIV-infected patients. Med Microbiol Immunol. 200(1): 39-49. www.ncbi.nlm.nih.gov/pubmed/20853118

Reuter S, Oette M, Wilhelm FC, Beggel B, Kaiser R, Balduin M, Schweitzer F, Verheyen J, Adams O, Lengauer T, Fatkenheuer G, Pfister H, Haussinger D. (2010). Prevalence and characteristics of hepatitis B and C virus infections in treatment-naive HIV-infected patients. Med Microbiol Immunol. www.ncbi.nlm.nih.gov/pubmed/20853118


Kupfer B, Ruf T, Matz B, Nattermann J, Spengler U, Rockstroh JK, Brackmann HH, Blumel J, Tacke M, Kaiser R. (2005). Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates. J Clin Virol. 34(1): 42-47. www.ncbi.nlm.nih.gov/pubmed/16087123

Kaiser R, Geulen O, Matz B, Brackmann HH, Spengler U, Kramer MH, Exner M, Nettekoven W, Ko YD, Zeitler H, Vetter H. (2002). Risk of hepatitis C after immunoadsorption. Infect Control Hosp Epidemiol. 23(6): 342-343. www.ncbi.nlm.nih.gov/pubmed/12083240

Duesberg U, Geulen O, Schneiders AM, Kaiser R, Brackmann HH, Matz B, Sauerbruch T, Spengler U. (2001). Transient loss of T-cell reactivity in a patient with hepatitis C virus reinfection. Digestion. 64(1): 66-70. www.ncbi.nlm.nih.gov/pubmed/11549839

Lechmann M, Woitas RP, Langhans B, Kaiser R, Ihlenfeldt HG, Jung G, Sauerbruch T, Spengler U. (1999). Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J Hepatol. 31(6): 971-978. www.ncbi.nlm.nih.gov/pubmed/10604568

Lechmann M, Schneider EM, Giers G, Kaiser R, Dumoulin FL, Sauerbruch T, Spengler U. (1999). Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection. Eur J Clin Invest. 29(4): 337-343. www.ncbi.nlm.nih.gov/pubmed/10231346